amitriptyline
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
1937
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
March 12, 2026
Neuropathic Pain Medications and Their Impact on Body-Focused Repetitive Behaviors in Patients with Cervical Spine Disorders: A Cross-Sectional Analysis
(AAD 2026)
- "Although response to N-acetylcysteine (11%) was poor, pregabalin (100%), gabapentin (67%), HRT (67%), SNRIs (60%), and amitriptyline (50%) observed greater positive response rates. In addition to highlighting C-spine diseases as notable comorbidities for BFRBs, this study suggests that combining neuropathic medications with behavioral therapy may offer an optimal treatment strategy for these patients. By emphasizing early detection and management of C-spine pathology, this approach provides a comprehensive framework, addressing potential anatomical contributors and improving overall therapeutic outcomes."
Clinical • Behavior Disorders • Mental Retardation • Neuralgia • Obsessive-Compulsive Disorder • Pain • Pruritus
January 10, 2026
What's in a Name: Interesting and Challenging Entities of the Tubular GI Tract
(USCAP 2026)
- "She was diagnosed with likely irritable bowel syndrome (IBS) and treated with amitriptyline and Buscopan...She was also prescribed a combination tablet of naproxen and esomeprozole to take during menstrual cycles...Examples from each of these categories will be reviewed with an emphasis on pitfalls that my lead to an erroneous diagnosis of IBD. Evening Specialty Presentation (PDF): Click to View"
Constipation • Crohn's disease • Gastrointestinal Disorder • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Bowel Disease • Ulcerative Colitis • IL17A
March 20, 2026
TOWARDS PATIENT-CENTERED CKD CARE: QUALITY OF LIFE AND SLEEP BURDEN AMONG PATIENTS IN NORTHERN TANZANIA
(ISN-WCN 2026)
- "Factors associated with poor sleep quality included Depression, Anxiety and use of amitriptyline. While factors associated with a low HRQoL was a history of hospital admission in the past 6 months and hypocalcemia.Conclusion These studies highlight important opportunities to improve the quality of CKD care in Tanzania by integrating patient-reported outcomes into routine clinical assessment. Efforts to look for ways to strengthen screening for depression, Anxiety and sleep disorders should be prioritized, alongside correction of modifiable biochemical abnormalities such as hypocalcemia represent focused areas of interventions to improve the HRQoL among patients at a tertiary hospital in northern Tanzania."
Clinical • HEOR • Chronic Kidney Disease • CNS Disorders • Depression • Endocrine Disorders • Mood Disorders • Nephrology • Sleep Disorder
March 25, 2026
Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association.
(PubMed, Eur J Neurol)
- "Integrated approaches combining migraine and sleep interventions show promise for symptom management. Further research is needed to refine treatment strategies and assess long-term effects."
Clinical • Journal • Review • CNS Disorders • Insomnia • Migraine • Pain • Sleep Disorder
March 25, 2026
Evidence-Based Nutritional Management of Menopausal Symptoms: A Pathophysiological Reasoning Approach to Personalized Nutrition Practice.
(PubMed, J Am Nutr Assoc)
- "Her headaches worsened and the MP prescribed amitriptyline (10 mg) toward the end of the therapy period. Her bone health was not measured. This case provides observational evidence of the potential efficacy of personalized nutrition utilizing pathophysiological reasoning to assess health status, an evidence-based approach to support intervention decisions and coaching skills to embed dietary change."
Journal • Fatigue • Osteoporosis • Pain • Rheumatology
March 25, 2026
Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial.
(PubMed, J Allergy Clin Immunol Pract)
- "In this trial, speech pathology effectively reduced ILO symptom severity and/or frequency in 73.7% of participants, with no additional benefit from concurrent amitriptyline."
Journal • Otorhinolaryngology • Pulmonary Disease
March 06, 2026
Does prophylactic low dose amitriptyline prevent post-herpetic neuralgia? findings from the ATHENA randomised placebo-controlled trial
(ESCMID Global 2026)
- No abstract available
Clinical • Late-breaking abstract • Neuralgia • Pain
March 20, 2026
The importance of central sensitization management in prosthodontic clinical practice: Two case reports of phantom bite syndrome.
(PubMed, J Prosthodont Res)
- "Maintaining pharmacotherapy throughout prosthetic treatment stabilized PBS symptoms, reduced relapse risk, and improved acceptance of definitive restorations. Recognition of possible central nervous system involvement, even without overt psychiatric comorbidity, broadens therapeutic options and supports better outcomes. Future studies should expand clinical case data, refine medication strategies, define optimal treatment timing, and strengthen interdisciplinary collaboration in PBS management."
Journal • Immunology • Psychiatry
March 21, 2026
Predicting the potential for organic cation transporter 1-mediated drug-drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil.
(PubMed, Expert Opin Drug Metab Toxicol)
- "An in vitro OCT1 inhibition assay using fenoterol as probe substrate was validated and identified that verapamil may pose a clinically relevant interaction risk, predicting a minimum 2-fold increase in fenoterol exposure. This highlights the need for caution when coadministrating verapamil with fenoterol and supports incorporating OCT1 inhibition profiling into preclinical evaluation of new drug entities to better inform clinical development and ensure patient safety."
Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases • SLC22A1
January 10, 2026
WHEN SEROTONIN BREAKS THE HEART: SEROTONIN SYNDROME-INDUCED TAKOTSUBO CARDIOMYOPATHY
(ACC 2026)
- "Her medications included amitriptyline, escitalopram, recent cyclobenzaprine, and tramadol taken one day prior...Offending agents were discontinued, and she was managed with supportive care, benzodiazepines, metoprolol, and continued home valsartan... SS is a rare but reversible trigger for TCM. Early recognition, withdrawal of serotonergic agents, and supportive therapy are critical to recovery and help avoid unnecessary prolonged anticoagulation or revascularization."
Acute Coronary Syndrome • Breast Cancer • Cardiomyopathy • Cardiovascular • CNS Disorders • Depression • Dyslipidemia • Heart Failure • Hypertension • Ophthalmology • Solid Tumor
March 16, 2026
MP-2019-001: TIMELAPSE study
(clinicaltrialsregister.eu)
- P3/4 | N=190 | Active, not recruiting | Sponsor: Ziekenhuis Gelderse Vallei Stichting | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Head-to-Head • CNS Disorders • Insomnia • Sleep Disorder
March 13, 2026
Cyclobenzaprine Reimagined: Clinical Insights Into Tonmya for Fibromyalgia.
(PubMed, J Pharm Technol)
- " Pharmacologic agents receive a weak recommendation for use in the treatment guidelines and include agents such as duloxetine, pregabalin, tramadol, amitriptyline, and a nonsublingual formulation of cyclobenzaprine. Tonmya, the newest agent approved for fibromyalgia, provides clinicians with an additional treatment option in a convenient dosage form for this potentially debilitating condition."
Journal • Review • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology
March 12, 2026
Accumulation and Metabolism of Wastewater-Derived Psychoactive Pharmaceuticals in Edible Crop Plants.
(PubMed, Environ Sci Technol)
- "To address this knowledge gap, semihydroponically grown lettuce, tomatoes, and carrots were exposed to four psychoactive pharmaceuticals─carbamazepine (CBZ), lamotrigine (LTG), amitriptyline (AMI), and fluoxetine (FLX)─for 28, 45, and 15 days, respectively. Liquid chromatography-high-resolution mass spectrometry analysis revealed 15, 7, 38, and 27 metabolites of CBZ, LTG, AMI, and FLX, respectively, including 15 novel in planta metabolites, among which were N-acylation products of the amine-containing LTG, AMI, and FLX. Similar metabolic pathways were observed across the three plant types, with the detection of more complex metabolites tied to higher tissue concentrations of parent compounds rather than to species specificity."
Journal
March 11, 2026
Advancing chronic low back pain management: Insights from amitriptyline and duloxetine comparison.
(PubMed, World J Methodol)
- "Although the absence of a placebo group limits causal inference, the study underscores the importance of individualized treatment strategies. We recommend further randomized controlled trials to validate these findings and strengthen evidence-based guidelines for CLBP management."
Journal • Back Pain • Lumbar Back Pain • Musculoskeletal Pain • Pain
March 11, 2026
Comparative effectiveness of amitriptyline vs duloxetine in the treatment of chronic low back pain: An observational study.
(PubMed, World J Methodol)
- "Amitriptyline and duloxetine effectively treat CLBP; however, considering side effects and more sustained pain relief, duloxetine appears to be the better option. Nonetheless, treatment choice should consider individual patient profiles."
HEOR • Journal • Observational data • Ankylosing Spondylitis • Back Pain • Constipation • Gastroenterology • Gastrointestinal Disorder • Immunology • Infectious Disease • Inflammatory Arthritis • Lumbar Back Pain • Musculoskeletal Diseases • Musculoskeletal Pain • Neuralgia • Oncology • Orthopedics • Pain • Rheumatology • Seronegative Spondyloarthropathies • Xerostomia
March 11, 2026
Prescription Trends and Clinical Decision-Making in Neuropathic Pain Pharmacological Treatment: Results From a Cross-Sectional Survey by the Spanish Pain Society.
(PubMed, Eur J Pain)
- "This nationwide survey provides the first systematic assessment of neuropathic pain management in Spain, revealing marked variability, only partial adherence to international guidelines, and persistent reliance on clinical experience over evidence. It confirms gabapentinoids, tricyclic antidepressants and duloxetine as preferred treatments, identifies continued tramadol use despite conflicting recommendations, and quantifies for the first time clinicians' perception and management of tolerance. These findings fill a major evidence gap and directly inform future national consensus, educational initiatives and clinical practice improvement."
Journal • Neuralgia • Pain
March 01, 2026
From Redox Imbalance to Tissue Injury: Insights Into Antidepressant Drug Amitriptyline Effects on Salivary Glands.
(PubMed, Cell Biochem Funct)
- "After the treatment period, saliva samples induced by pilocarpine were collected to analyze total protein concentration, amylase activity, and antioxidant capacity, while salivary glands were harvested for assessments of oxidative stress markers and morphological changes. In the submandibular gland, acinar area was reduced as well. These findings suggest that amitriptyline-salivary gland dysfunction is associated with oxidative imbalance, morphometric, and alterations in saliva composition, contributing to a broader understanding of amitriptyline's adverse effects."
Journal
March 06, 2026
Amitriptyline for Acute Mild Traumatic Brain Injury (mTBI)
(AAN 2026)
- "Data from our clinic reveals that patients presenting with more severe symptoms and a history of comorbidities considered risk factors for prolonged recovery were prescribed amitriptyline, which was beneficial in achieving full recovery defined as complete resolution of symptoms. Our results suggest that amitriptyline is a viable pharmacological option in treating mTBI symptoms, and may prevent lingering effects in a patient subset vulnerable to prolonged recovery, those with a history of depression."
CNS Disorders • Depression • Migraine • Vascular Neurology
March 06, 2026
Post Traumatic Headache Worsened by Subgaleal Hematoma Secondary to Tight Braids in an Adolescent Male
(AAN 2026)
- "He was prescribed amitriptyline for treatment of post-traumatic headaches... Post-traumatic headaches are a common sequela following head or neck trauma, and often self-resolving. Subgaleal hematoma can be a rare complication of tight hairstyles. In our case, the SGH likely contributed to a protracted course and complicated the headache presentation."
CNS Disorders • Migraine • Pain
March 06, 2026
Pain Treatment Strategy and Readmission Rates for Medicare Beneficiaries Post-acute Ischemic Stroke
(AAN 2026)
- "Individuals met insurance coverage criteria and did not take recommended pharmacological treatments for neuropathic pain (gabapentin, pregabalin, amitriptyline, lamotrigine, carbamazepine, and phenytoin) before hospitalization. We found no significant difference in hospital readmission rates between gabapentin and other post-stroke pain treatment strategies. Our findings contribute to the pharmacovigilance of gabapentin in real-world Medicare beneficiaries post-AIS."
Medicare • Reimbursement • US reimbursement • Cardiovascular • CNS Disorders • Epilepsy • Ischemic stroke • Musculoskeletal Pain • Neuralgia • Pain
March 06, 2026
Medical Cannabis for the Treatment of Insomnia: A Cochrane Systematic Review and Meta-analysis
(AAN 2026)
- "Eight studies compared MC with placebo, and one compared it with amitriptyline... The studies analyzed to date suggest that MC has little or no effect on adult insomnia outcomes, with very low certainty of evidence. It´s recommended that, based on these preliminary analyses, further RCTs are required to address methodological limitations."
Retrospective data • Review • CNS Disorders • Insomnia • Sleep Disorder
March 06, 2026
Melatonin for Migraine Prevention in Children and Adolescents: A Systematic Review of Randomized Controlled Trials
(AAN 2026)
- "Melatonin is a safe and well-tolerated preventive treatment for pediatric migraine; however, it has not demonstrated superiority to placebo and appears less effective than amitriptyline. These conclusions are based on limited evidence, underscoring the need for larger trials to better define its potential role in therapy."
Clinical • Review • CNS Disorders • Migraine • Pain
March 05, 2026
Vulvodynia integrative approach with acupuncture – case report and study protocol for clinical applications
(ISGE 2026)
- "In the past years she had undergone multiple pharmacological treatments such as oral venlafaxine, amitriptyline, gabapentin. our case report regards a patient with chronic vulvodynia treated with acupuncture with satisfying results, with no concomitant treatment with opioid or neuroactive drugs. Based on this result, we decided to develop a study protocol in our clinic to be offered both to treated and non treated patients, with standardized acupuncture points and replicable outcome measurements. An integrative approach in the management of vulvodynia with acupuncture, such as for many other chronic pain diseases, appears promising, well tolerated by patients and worth for research."
Case report • Clinical • Women's Health
March 05, 2026
Repurposed amitriptyline hydrochloride against fluconazole-resistant Candida albicans targeting efflux pump Pdr5, an ABC transporter: In vitro and in silico study with clinical validation.
(PubMed, Diagn Microbiol Infect Dis)
- "The overall results demonstrate that AMP exerts significant antifungal effects against fluconazole resistant C. albicans, disrupting biofilm formation and promoting wound healing in vivo, and also overcoming to fight fluconazole resistant clinical isolates. These findings suggest that AMP holds promise as an alternative therapeutic strategy for managing resistant candidiasis and warrant further investigation in clinical settings."
Journal • Preclinical • Candidiasis • CAT
March 04, 2026
Acute PGAD-Like Genital Arousal in a 59-Year-Old Woman After Duloxetine Withdrawal: A 36-Month Follow-Up Case Report.
(PubMed, Curr Ther Res Clin Exp)
- "We report the case of a 59-year-old woman who experienced an acute episode of genital arousal symptoms consistent with Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia (PGAD/GPD), but not fulfilling the duration criterion. She was managed with rapid multidisciplinary assessment and short-term intravenous clorazepate and amitriptyline, together with analgesics, while the episode remained self-limited and resolved spontaneously within 5 hours after admission. This case aims to raise awareness among clinicians about acute PGAD-like genital arousal episodes potentially associated with antidepressant withdrawal, the need to carefully review medication histories, and the high level of distress and even suicidality that may accompany these symptoms."
Journal • CNS Disorders • Depression • Mood Disorders • Pain • Psychiatry • Sexual Disorders
1 to 25
Of
1937
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78